Our Experts

Name: Wu Xingping
Title: Associate Chief Technician
Email: wuxp@sysucc.org.cn
Phone:
Profile
Dr. Wu Xingping  is an associate chief technician and team leader of Immunizations. He has been engaging himself in clinical laboratory in the Department of Laboratory Medicine since his graduation in July 1991, being familiar with various laboratory techniques and procedures. He is now in charge of the Immunizations Team, participating in teaching and scientific research.
Interests
Mainly focus on laboratory and research on cancer immunization
Education
Publications

1. Wu Xingping*, Zhang Lin, Tan Xiaoli, Liu Xiaomin, He Lirong, Pathogen Spectrum and Drug Resistance of Spit Samples from Cancer Patients, Chinese Journal of Cancer, Vol. 26, Issue 12, Page 1336-1338, 2007

2. Wu Xingping*, Zhang Lin, Tan Xiaoli, Liu Xiaomin, He Lirong, Pathogens Spectrum and Drug Resistance of Nosocomial Infection in Cancer Patients, Chinese Journal of Nosocomiology, Vol. 19, Issue 20, Page 2801-2803, 2009

3. Wu Xingping*, Liu Xiaohua, Liu Xiaomin, Zhong Yifu, Tan Xiaoli, He Lirong, The Influence of Specimen Factor in Serum Neuron Specific Enolase Detection and Its Clinical Application to Lung Cancer, Chinese Journal of Cancer Prevention and Treatment, Vol. 16, Issue 20, Page 10-12, 2009

4. Wu Xingping*, Chen Hao, Liu Xiaohua, Zeng Qiuyao, Dai Shuqin, Significance of Combined Detection of Serum Cyfra21-1 and NSE and Ferritin in Diagnosis of Lung Cancer, Journal of Tropical Medicine, Vol. 10, Issue 7, Page 838-841, 2010

5. Wu Xingping*, Chen Yueqiong, Lai Changchun, Zeng Qiuyao, Peng Xiongwen, Diagnosis value of combining testing peripheral blood and serum levels of CEA and TSGF and carbohydrate antigen for patients with gastric cancer, Chinese Journal of Cancer Prevention and Treatment, Vol. 18, Issue 21, Page 1688-1707, 2011

6. Wu Xingping*, Zeng Qiuyao, Li Linfang, Zeng Jing, Wu Mingwei*, Clinical value of serum neuro-specific enolase for patients with lung cancer, Lingnan Modern Clinics in Surgery, Vol. 12, Issue 3, Page 199-201, 2012

7. Wu Xingping*, Zeng Qiuyao, Zhang Lin, Huang Zhong, He Lirong, The Clinical Value of Combined Dectection of CA125, CA72-4 and Ferritin in Patients with Ovarian Cancer, Journal of Tropical Medicine, Vol. 10, Issue 4, Page 431-433, 2010

8. Guang-quan Li, Xing-gui Chen, Xing-ping Wu, Xing-dun Xie, Yong-ju Liang, Xiao-qinZhao, Wei-qiang Chen,Li-wu Fu,Effect of Dicycloplatin,a Novel Plantinum Chemotherapeutical Drug,on Inhibiting Cell Growth and Inducing Cell Apoptosis,PLOS ONE, 7(11),1-13,2012

9. Fang Wang,Yong-ju Liang, Xing-ping Wu,Li-ming Chen,Kenneth Kin Wah To,Chun-ling Dai,Yan-yan Yan,Yan-sheng Wang,Xiu-zhen Tong,Li-wu Fu, Prognostic value  of  the multidrug resistance transporter ASCG2 gene polymorphisms in Chinese patients with de novo acute leukaemia ,EUROPEAN JOURNAL OF CANCER, 47, 1990-1999,2011

10. Fang Wang, Yan-jun Mi, Xing-Gui Chen, Xing-ping Wu, Zhenguo Liu, Shu-peng Chen, Yong-ju Liang, Chao Cheng, Kenneth Kin Wah To, and Li-wu Fu, Axitinib Targeted Cancer Stemlike Cells to Enhance Efficacy of  Chemotherapeutic Drugs via Inhibiting the Drug Transport Function of ABCG2, Molecular Medicine, 18:887-898,2012

11. Wu Xingping, Zhang Lin*, Ding Weilong, Yang Juan, Liu Wanli, Clinical value of combined detection of Cyfra21-1 ,CEA and CRP for esophageal cancer, Chinese Journal of Cancer Prevention and Treatment, Vol. 19, Issue 10, Page 667-670, 2012

12. Wang Xiaopai, Wu Xingping, Yan Lixu, Shao Jianyong*, Serum miR-103 as a potential diagnostic biomarker for breast cancer, Journal of Southern Medical University, Vol. 32, Issue 5, Page 631-634, 2012

13. Ran, ZH; Xiao, SD; Chen, MH; Hu, PJ; Qian, JM; Wu, XP; Ouyang, Q; Zhang, H; Wang, YF; Xia, B; Deng, CS; Zheng, JJ; Pang, Z; Xie, Y; Lv, NH; Li, KD; Tan, H; Liu, XG; Wu, KC; Li, YQ, Retrospective analysis of 515 cases of Crohn's disease hospitalization in China: Nationwide study from 1990 to 2003, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 21(6), pp 1009-1015, 2006/6. Journal paper

14. Kuang, MH; Ouyang, WT; Lin, JH; Wu, XP, Clinical evaluation of three tumor markers in hepatocellular carcinoma diagnosis: alpha-fetoprotein-L3, des-gamma-carboxy prothrombin and alpha-fetoprotein, Chinese Archives of General Surgery (Electronic Edition), Issue 04, 2010/8/1. Journal paper

15. Liu, XM; Dai, SQ; Wu, XP; He, LR, Analysis of Relativity on β-HCG of twoChemilumincscence Immunoassay Systems Conclusion β-HCG results between two different detection systems are consistent, Chinese Journal of Ethnomedicine and Ethnopharmacy, Issue 21, 2009/11/15. Journal paper







Updated by International Office, Sun Yat-sen University Cancer Center


 

Where are we | Contact us|

Copyright:Sun Yat-sen University Cancer Center Designed by Wanhu.